Delta‐Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma

PURPOSE: Delta‐like protein 3 (DLL3) is being developed as a predictive biomarker for DLL3‐targeting antibody‐drug conjugate and other therapies. Given the neuroendocrine features of Merkel cell carcinoma (MCC), we sought to evaluate DLL3 expression and its role in MCC. EXPERIMENTAL DESIGN: Formalin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Xie, Hao, Kaye, Frederic J., Isse, Kumiko, Sun, Yan, Ramoth, Johanna, French, Dorothy M., Flotte, Thomas J., Luo, Yan, Saunders, Laura R., Mansfield, Aaron S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Melanoma and Cutaneous Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485334/
https://ncbi.nlm.nih.gov/pubmed/32372416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0877
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados